California launched state-branded insulin this year, but it’s been slow to reach patients
California Gov. Gavin NewsomHeather Diehl/Getty Images
By Angela Hart — KFF Health NewsAug. 13, 2026
STAT is co-publishing this article by KFF Health News.
SAN FRANCISCO — At a Walgreens in this city’s bustling Japantown neighborhood, pharmacist Margaret On stocks two boxes of long-acting insulin pens from California’s new prescription drug label, CalRx, emblazoned with the state’s iconic grizzly bear.








